← Back to Clinical Trials
Recruiting NCT06969235

NCT06969235 Examining the Role of Executive Functioning in Family-Based Intensive Health Behavior and Lifestyle Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06969235
Status Recruiting
Phase —
Sponsor University of Missouri-Columbia
Condition Pediatric Overweight
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2025-05-05
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
intensive health behavior and lifestyle treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2025-05-05 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objectives of this open trial feasibility study are to examine the impacts of intensive health behavior and lifestyle treatment (IHBLT) on youth and caregiver executive functioning (EF), weight status, health behaviors (dietary intake, disordered eating, physical activity), and psychological functioning. Investigators propose to enroll 10 youth 13 to 17 years of age who have overweight or obesity (OV/OB) and a primary caregiver. Families will receive six months of evidence-based family focused group IHBLT based on social, cognitive, and family systems theories. Families will complete assessments of EF skills (objective and self-report), weight status, dietary intake, physical activity, and psychological functioning at pre- and post-treatment.

Eligibility Criteria

Inclusion Criteria: * Youth 13-17 years old * Youth with OV/OB (BMI≥85th percentile for age/gender norms) * Participating caregiver must be the participating youth's legal guardian * Participating youth and caregiver speak and read English * Participating youth and caregiver agree to attend IHBLT group meetings in-between the pre- and post-treatment assessments. Exclusion Criteria: * Youth pervasive developmental disorder (e.g., intellectual disability) * Youth or caregiver in commercial weight loss program or taking prescribed medications for the prior three months that impact appetite or weight * Youth or caregiver with documented history of eating disorder or untreated severe depression * Both youth and caregiver scores are two standard deviations or above the mean on the CPT-3 Commissions and Stroop Interference, representing significantly higher than average EF skills.

Contact & Investigator

Principal Investigator

Crystal Lim, PhD, ABPP

PRINCIPAL INVESTIGATOR

University of Missouri-Columbia

Frequently Asked Questions

Who can join the NCT06969235 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying Pediatric Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06969235 currently recruiting?

Yes, NCT06969235 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Missouri-Columbia to inquire about joining.

Where is the NCT06969235 trial being conducted?

This trial is being conducted at Columbia, United States.

Who is sponsoring the NCT06969235 clinical trial?

NCT06969235 is sponsored by University of Missouri-Columbia. The principal investigator is Crystal Lim, PhD, ABPP at University of Missouri-Columbia. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology